Loading clinical trials...
Loading clinical trials...
This study took FT1D(fulminant type 1 diabetes) as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Second Xiangya Hospital of Central South University
NCT07222137 · Diabetes Mellitus, Type 1
NCT06807190 · Diabetes Mellitus, Type 1
NCT07160816 · Diabetes Mellitus, Type 1
NCT04786262 · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, and more
NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism
Quanzhou First People's Hospital
Quanzhou, Fujian
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions